Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
14 studies found for:    "Fibrous dysplasia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
2 Completed Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention: Drug: Fosamax (Alendronate)
3 Completed Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
4 Recruiting TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE
Condition: Fibrous Dysplasia of Bone
Interventions: Drug: Tocilizumab;   Drug: Placebo
5 Unknown  Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
Condition: Fibrous Dysplasia of Bone
Interventions: Drug: risedronate;   Drug: placebo
6 Completed Bone Marrow Injection to Replace Diseased Bone in Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
7 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
8 Completed A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia
Intervention: Drug: Pegvisomant
9 Completed Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Conditions: Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Testolactone
10 Active, not recruiting Arimidex in McCune Albright Syndrome
Condition: McCune-Albright Syndrome
Intervention: Drug: Arimidex 1 mg
11 Unknown  Histamine Responsiveness in McCune-Albright Syndrome
Condition: McCune-Albright Syndrome
Intervention:
12 Active, not recruiting
Has Results
Faslodex in McCune Albright Syndrome
Conditions: Puberty, Precocious;   McCune-Albright Syndrome
Intervention: Drug: Fulvestrant
13 Recruiting Genetic and Functional Analysis of Cherubism
Condition: Cherubism
Intervention:
14 Recruiting Natural History of Cherubism Observational Study
Condition: Cherubism
Intervention: Other: no interventions

Indicates status has not been verified in more than two years